Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2702)

Porto 4200-072

2 studies enrolling now · 2 studies all time

What they study most

Non Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) — Recruiting now
• A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) — Recruiting now